Mr. Peter Bakema reports

CVR MEDICAL ANNOUNCES CLOSING OF TEMPORARY WARRANT EXERCISE PRICE AMENDMENT

CVR Medical Corp.'s temporary warrant exercise price amendment expired at the close of business on April 6, 2018. An aggregate of 2,518,600 warrants originally issued in the February and April, 2017, private placements, were exercised for gross proceeds of $1,007,440. CVR Medical also issued a total of 2,518,600 new warrants to those holders who exercised their 2017 warrants. The new warrants have an exercise price of $1.50 and will expire on April 9, 2020.

In the amendment closing, CVR Medical paid finders' fees of 5 per cent in cash composed of an aggregate cash commission of $22,811.14.

The new warrants and any common shares issued upon the exercise of the new warrants are subject to a hold period expiring on Aug. 10, 2018. The amendment remains subject to final acceptance of the TSX Venture Exchange.

About CVR Medical Corp.

CVR Medical is a company that is involved in an equal-part joint venture with CVR Global Inc. The joint venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic and low-frequency sound wave analysis technology, and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team.

We seek Safe Harbor.